Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Related Articles by Review for PubMed (Select 20524301)

1.

The fate of anti-HLA antibody among renal transplantation recipients treated with bortezomib.

Lonze BE, Dagher NN, Simpkins CE, Singer AL, Segev DL, Zachary AA, Montgomery RA.

Clin Transpl. 2009:377-84.

PMID:
20524301
2.

Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation.

Sureshkumar KK, Hussain SM, Marcus RJ, Ko TY, Khan AS, Tom K, Vivas CA, Parris G, Jasnosz KM, Thai NL.

Clin Nephrol. 2012 Mar;77(3):246-53. Review.

PMID:
22377258
3.

Bortezomib: a new player in pre- and post-transplant desensitization?

Lemy A, Toungouz M, Abramowicz D.

Nephrol Dial Transplant. 2010 Nov;25(11):3480-9. doi: 10.1093/ndt/gfq502. Epub 2010 Sep 8. Review.

4.

Proteasome inhibition for antibody-mediated rejection.

Everly JJ, Walsh RC, Alloway RR, Woodle ES.

Curr Opin Organ Transplant. 2009 Dec;14(6):662-6. doi: 10.1097/MOT.0b013e328330f304. Review.

PMID:
19667989
5.

Proteasome inhibitor therapy for antibody-mediated rejection.

Woodle ES, Walsh RC, Alloway RR, Girnita A, Brailey P.

Pediatr Transplant. 2011 Sep;15(6):548-56. doi: 10.1111/j.1399-3046.2011.01543.x. Review.

PMID:
21884344
6.

Clinical and investigational use of proteasome inhibitors for transplant rejection.

Sadaka B, Alloway RR, Woodle ES.

Expert Opin Investig Drugs. 2011 Nov;20(11):1535-42. doi: 10.1517/13543784.2011.618494. Epub 2011 Sep 15. Review.

PMID:
21916809
7.

The use of bortezomib as a rescue treatment for acute antibody-mediated rejection: report of three cases and review of literature.

Tzvetanov I, Spaggiari M, Joseph J, Jeon H, Thielke J, Oberholzer J, Benedetti E.

Transplant Proc. 2012 Dec;44(10):2971-5. doi: 10.1016/j.transproceed.2012.02.037. Review.

PMID:
23195008
8.

Desensitization across the HLA barrier in kidney transplantaion.

Mohamed MA, Lorentzen D, Kim J, Djamali A.

Front Biosci (Schol Ed). 2011 Jun 1;3:929-36. Review.

PMID:
21622242
9.
10.

The role of bortezomib in the treatment of lymphoma.

Barr P, Fisher R, Friedberg J.

Cancer Invest. 2007 Dec;25(8):766-75. Review.

PMID:
18058474
11.

The state of therapy for removal of alloantibody producing plasma cells in transplantation.

Everly MJ, Terasaki PI.

Semin Immunol. 2012 Apr;24(2):143-7. doi: 10.1016/j.smim.2011.08.014. Epub 2011 Dec 5. Review.

PMID:
22153981
12.

Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies.

Caravita T, de Fabritiis P, Palumbo A, Amadori S, Boccadoro M.

Nat Clin Pract Oncol. 2006 Jul;3(7):374-87. Review.

PMID:
16826218
13.

Review of bortezomib treatment of antibody-mediated rejection in renal transplantation.

Ejaz NS, Alloway RR, Halleck F, Dürr M, Budde K, Woodle ES.

Antioxid Redox Signal. 2014 Dec 10;21(17):2401-18. doi: 10.1089/ars.2014.5892. Epub 2014 Apr 28. Review.

PMID:
24635140
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk